Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Jiangsu Richen-Bases Bio & Sci Co. Ltd. is active in the Biotechnology & Pharmaceuticals technology area. The company's patent prosecution profile is currently defined by 1 pending office action. This 1 pending office action represents the entirety of the company's current workload before the USPTO.
The examination process for this company is localized within 1 distinct examiner and 1 distinct art unit. The busiest examiner for the portfolio is ROGERS, JAMES WILLIAM, who is managing 1 pending office action. With only 1 distinct examiner involved, the applicant faces a very specific set of examination criteria.
Practitioners can focus their efforts on the specific tendencies of ROGERS, JAMES WILLIAM, as this individual holds the company's pending office action load. This streamlined prosecution environment in the Biotechnology & Pharmaceuticals sector allows for a singular focus on the issues raised in the 1 pending action. The involvement of 1 distinct art unit further ensures that the technical review remains within a specialized group.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ROGERS, JAMES WILLIAM | 1 | 46.2% | +22.3% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18288937 | 13C METHACETIN GRANULE, AND PREPARATION METHOD THEREFOR AND USE THEREOF | ROGERS, JAMES WILLIAM | — |
| Art Unit | Apps |
|---|---|
| 1618 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18288937 | 13C METHACETIN GRANULE, AND PREPARATION METHOD THEREFOR AND USE THEREOF | ROGERS, JAMES WILLIAM | 1618 | §103 | Non-Final OA | — | Pending | Oct 30, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial